3151 - 3200 of 8399 Results
Title
Year
-
OPENTitle: Forward and backward walking share the same motor modules and locomotor adaptation strategiesJournal Name: HeliyonPublisher: Elsevier BVVol: 7Issue #: 8Start Page: e07864End Page: e07864Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.heliyon.2021.e07864Best OA location URL: http://www.cell.com/article/S2405844021019678/pdfCitation Count: 11
-
OPENTitle: Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 80Issue #: 8Start Page: 741End Page: 753Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlab056Best OA location URL: https://academic.oup.com/jnen/article-pdf/80/8/741/40347160/nlab056.pdfCitation Count: 11
- Membrane‐destabilizing ionizable lipid empowered imaging‐guided siRNA delivery and cancer treatment2021OPENTitle: Membrane‐destabilizing ionizable lipid empowered imaging‐guided siRNA delivery and cancer treatmentJournal Name: ExplorationPublisher: WileyVol: 1Issue #: 1Start Page: 35End Page: 49Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/exp.20210008Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/EXP.20210008Citation Count: 96
-
RESTRICTEDTitle: Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1998End Page: 1999Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28678Citation Count: 0
-
RESTRICTEDTitle: Reply to: “Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1999End Page: 2000Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28697Citation Count: 0
-
RESTRICTEDTitle: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 8Start Page: 1451End Page: 1457Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01455-xBest OA location URL: https://discovery.ucl.ac.uk/10134438/1/Dam%20%20%20%20PASSPORT%20Primary%20MS%20rev%20NMED-A110517A%20Final%20PIPE-18442%20w%20Figs.pdfCitation Count: 103
-
OPENTitle: Uremic Striatopallidal Syndrome Manifesting as Acute Onset ChoreaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13285Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13285Citation Count: 2
-
RESTRICTEDTitle: Deep brain stimulation programming strategies: segmented leads, independent current sources, and future technologyJournal Name: Expert Review of Medical DevicesPublisher: Informa UK LimitedVol: 18Issue #: 9Start Page: 875End Page: 891Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17434440.2021.1962286Citation Count: 11
-
OPENTitle: Auditory and olfactory findings in patients with USH2A‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A‐related retinal degeneration natural history study (RUSH2A)Journal Name: American Journal of Medical Genetics Part APublisher: WileyVol: 185Issue #: 12Start Page: 3717End Page: 3727Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ajmg.a.62437Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717864Citation Count: 9
-
OPENTitle: Dream Content Predicts Motor and Cognitive Decline in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1041End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13318Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13318Citation Count: 10
-
RESTRICTEDTitle: Emerging hiPSC Models for Drug Discovery in Neurodegenerative DiseasesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 15Start Page: 8196End Page: 8196Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22158196Best OA location URL: https://www.mdpi.com/1422-0067/22/15/8196/pdf?version=1627640850Citation Count: 11
-
OPENTitle: From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's diseaseJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 14Start Page: 2945End Page: 2951Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bcj20210383Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/14/2945/918073/bcj-2021-0383.pdfCitation Count: 4
- Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change2021OPENTitle: Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of ChangeJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2853End Page: 2861Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28730Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688189Citation Count: 11
-
OPENTitle: The mechanisms of smell loss after SARS-CoV-2 infectionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 9Start Page: 693End Page: 695Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00202-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324112Citation Count: 12
-
OPENTitle: A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation in a cellular model of Huntington’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 7Start Page: e0254834End Page: e0254834Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0254834Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0254834&type=printableCitation Count: 11
-
OPENTitle: Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learningJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 3Issue #: 9Start Page: e555End Page: e564Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s2589-7500(21)00101-1Best OA location URL: http://www.thelancet.com/article/S2589750021001011/pdfCitation Count: 62
-
OPENTitle: The effects of mood and cognition on daily functioning and quality of life in older people living with HIV and people with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 35Issue #: 7Start Page: 691End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1037/neu0000760Best OA location URL: https://doi.org/10.1037/neu0000760Citation Count: 2
-
OPENTitle: A Multi‐center Genome‐wide Association Study of Cervical DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2795End Page: 2801Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28732Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688173Citation Count: 8
-
RESTRICTEDTitle: Men with FMR1 premutation alleles of less than 71 CGG repeats have low risk of being affected with fragile X-associated tremor/ataxia syndrome (FXTAS)Journal Name: Journal of Medical GeneticsPublisher: BMJVol: 59Issue #: 7Start Page: 706End Page: 709Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jmedgenet-2021-107758Citation Count: 5
-
OPENTitle: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 604Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990146Citation Count: 53
-
OPENTitle: TikTok Tics: A Pandemic Within a PandemicJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 8Start Page: 1200End Page: 1205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13316Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13316Citation Count: 123
-
OPENTitle: A Blueprint for the Conduct of Large, Multisite Trials in TelemedicineJournal Name: Journal of Medical Internet ResearchPublisher: JMIR Publications Inc.Vol: 23Issue #: 9Start Page: e29511End Page: e29511Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/29511Best OA location URL: https://www.jmir.org/2021/9/e29511/PDFCitation Count: 2
-
OPENTitle: A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson’s diseaseJournal Name: Expert Opinion on Drug DeliveryPublisher: Informa UK LimitedVol: 18Issue #: 11Start Page: 1559End Page: 1569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/17425247.2021.1960820Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/17425247.2021.1960820?needAccess=trueCitation Count: 14
-
OPENTitle: Advanced Machine Learning Tools to Monitor Biomarkers of Dysphagia: A Wearable Sensor Proof-of-Concept StudyJournal Name: Digital BiomarkersPublisher: S. Karger AGVol: 5Issue #: 2Start Page: 167End Page: 175Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000517144Best OA location URL: https://www.karger.com/Article/Pdf/517144Citation Count: 26
-
OPENTitle: Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in miceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-24567-xBest OA location URL: https://www.nature.com/articles/s41467-021-24567-x.pdfCitation Count: 9
-
OPENTitle: Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegenerationJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 693Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.abg3555Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486338Citation Count: 26
-
OPENTitle: Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on AgingJournal Name: Journal of Clinical Sleep MedicinePublisher: American Academy of Sleep Medicine (AASM)Vol: 18Issue #: 2Start Page: 345End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5664/jcsm.9562Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804990Citation Count: 9
-
OPENTitle: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 27End Page: 32Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024Best OA location URL: http://manuscript.elsevier.com/S135380202100273X/pdf/S135380202100273X.pdfCitation Count: 16
-
RESTRICTEDTitle: Plasma membrane calcium ATPase downregulation in dopaminergic neurons alters cellular physiology and motor behaviour in Drosophila melanogasterJournal Name: European Journal of NeurosciencePublisher: WileyVol: 54Issue #: 6Start Page: 5915End Page: 5931Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.15401Citation Count: 4
-
OPENTitle: A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 3Start Page: 399End Page: 421Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02349-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02349-5.pdfCitation Count: 21
-
RESTRICTEDTitle: Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00203-9Best OA location URL: https://www.nature.com/articles/s41531-021-00203-9.pdfCitation Count: 83
-
RESTRICTEDTitle: Biomedical Research COVID-19 Impact Assessment: Lessons Learned and Compelling NeedsJournal Name: NAM PerspectivesPublisher: National Academy of MedicineVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.31478/202107eBest OA location URL: https://europepmc.org/articles/pmc8486427?pdf=renderCitation Count: 6
-
OPENTitle: Distinct progression patterns across Parkinson disease clinical subtypesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 8Start Page: 1695End Page: 1708Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51436Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51436Citation Count: 7
-
OPENTitle: Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European AmericansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 4Start Page: 572End Page: 580Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12435Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789942Citation Count: 28
-
RESTRICTEDTitle: LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 11Issue #: 8Start Page: 1101End Page: 1101Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom11081101Best OA location URL: https://www.mdpi.com/2218-273X/11/8/1101/pdf?version=1627473313Citation Count: 26
-
OPENTitle: A high dose tango intervention for people with Parkinson's disease (PwPD)Journal Name: Advances in Integrative MedicinePublisher: Elsevier BVVol: 8Issue #: 4Start Page: 272End Page: 277Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.aimed.2021.07.005Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2019/04/18/613661.full.pdfCitation Count: 4
-
RESTRICTEDTitle: A Role of Aging in the Progression of Cortical Excitability in Benign Adult Familial Myoclonus Epilepsy type 1 PatientsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2446End Page: 2448Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28718Citation Count: 7
-
RESTRICTEDTitle: Beyond tics: movement disorders in patients with Tourette syndromeJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 128Issue #: 8Start Page: 1177End Page: 1183Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-021-02386-0Citation Count: 17
-
RESTRICTEDTitle: Fast and robust supervised machine learning approach for classification and prediction of Parkinson’s disease onsetJournal Name: Computer Methods in Biomechanics and Biomedical Engineering: Imaging & VisualizationPublisher: Informa UK LimitedVol: 9Issue #: 6Start Page: 690End Page: 706Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/21681163.2021.1941262Citation Count: 6
-
OPENTitle: Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)Journal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02308-3Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-021-02308-3Citation Count: 33
-
OPENTitle: Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson DiseaseJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000001036Best OA location URL: https://nn.neurology.org/content/nnn/8/5/e1036.full.pdfCitation Count: 85
-
RESTRICTEDTitle: No effect of Parkinson’s disease-polygenic load on striatal density of dopaminergic neuron in healthy subjectsJournal Name: Annals of Nuclear MedicinePublisher: Springer Science and Business Media LLCVol: 35Issue #: 11Start Page: 1187End Page: 1192Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12149-021-01657-wCitation Count: 1
-
OPENTitle: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐upJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2257Best OA location URL: https://doi.org/10.1002/brb3.2257Citation Count: 15
-
OPENTitle: Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 DiabetesJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1322End Page: 1337Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.1c00028Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369672Citation Count: 15
-
OPENTitle: The Discovery of α‐Synuclein in Lewy Pathology of Parkinson's Disease: The Inspiration of a RevolutionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 8Start Page: 1189End Page: 1193Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13312Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13312Citation Count: 2
-
OPENTitle: BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 6Start Page: 846End Page: 853Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1111/ner.13504Best OA location URL: http://manuscript.elsevier.com/S1094715922000460/pdf/S1094715922000460.pdfCitation Count: 9
- International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease2021OPENTitle: International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2583End Page: 2594Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28706Best OA location URL: https://air.unimi.it/bitstream/2434/968045/2/Movement%20Disorders%20-%202021%20-%20Laansma%20-%20International%20Multicenter%20Analysis%20of%20Brain%20Structure%20Across%20Clinical%20Stages%20of.pdfCitation Count: 99
- Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of life2021OPENTitle: Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of lifeJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 8Start Page: 1668End Page: 1679Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51424Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/169327/2/acn351424.pdfCitation Count: 9
-
OPENTitle: Temporal trajectory of biofluid markers in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-94345-8Best OA location URL: https://www.nature.com/articles/s41598-021-94345-8.pdfCitation Count: 19
-
OPENTitle: Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory ModelsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1083End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13311Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13311Citation Count: 7